Prime Medicine to Participate in Upcoming Investor Conferences Aug 26, 2025 08:00AM
Citizens JMP Reiterates Market Outperform Rating on Prime Medicine (PRME) Jul 21, 2025 04:12AM
Citizens JMP Reiterates Market Outperform Rating on Prime Medicine (PRME) Jun 18, 2025 04:47AM
Citi Downgrades Prime Medicine (PRME) to Neutral, 'Financing Risk Muddles the Path to Value Inflection' May 27, 2025 03:49AM
Citi on Prime Medicine (PRME) with shares down 20pct: 'Initial Human Data from a Prime Editing Therapy Show Promise, but Financing Risk Remains a Key Overhang' May 19, 2025 10:28AM


Mar 19, 2025 04:12AM Citizens JMP Reiterates Market Outperform Rating on Prime Medicine (PRME)
Mar 4, 2025 04:34AM Citizens JMP Reiterates Market Outperform Rating on Prime Medicine (PRME)
Sep 30, 2024 04:02PM Citi Reiterates Buy Rating on Prime Medicine (PRME)
May 16, 2024 05:10AM Citi Upgrades Prime Medicine (PRME) to Buy
Jan 5, 2024 08:00AM Prime Medicine (PRME) Appoints Allan Reine, M.D., as Chief Financial Officer
Jan 5, 2024 08:00AM Prime Medicine Appoints Allan Reine, M.D., as Chief Financial Officer
Dec 8, 2023 05:53AM Citi Starts Prime Medicine (PRME) at Neutral